These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38829138)

  • 1. A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses.
    Lu J; Liu J; Wu Y; He X; Gao X; Chen X; Chen S; Zhu X; Peng Y; Xiao G; Pan X
    J Virol; 2024 Jul; 98(7):e0076924. PubMed ID: 38829138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
    Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice.
    Kang JG; Jeon K; Choi H; Kim Y; Kim HI; Ro HJ; Seo YB; Shin J; Chung J; Jeon YK; Kim YS; Lee KH; Cho NH
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007813. PubMed ID: 32196487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses.
    Wu X; Moming A; Zhang Y; Wang Z; Zhang T; Fu L; Qian J; Ni J; Hu S; Tang S; Zheng X; Wang H; Shen S; Deng F
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012216. PubMed ID: 38848311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome.
    Yoshikawa T; Taniguchi S; Kato H; Iwata-Yoshikawa N; Tani H; Kurosu T; Fujii H; Omura N; Shibamura M; Watanabe S; Egawa K; Inagaki T; Sugimoto S; Phanthanawiboon S; Harada S; Yamada S; Fukushi S; Morikawa S; Nagata N; Shimojima M; Saijo M
    PLoS Pathog; 2021 Feb; 17(2):e1008859. PubMed ID: 33534867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing and characterizing monoclonal antibodies of Guertu bandavirus nucleoprotein for developing methods of Guertu bandavirus and severe fever with thrombocytopenia syndrome virus detection.
    Qian J; Fu L; Wu X; Wang Z; Wang H; Zeng Y; Cheng G; Deng F; Shen S
    Braz J Microbiol; 2023 Sep; 54(3):1433-1445. PubMed ID: 37225938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neutralizing Monoclonal Antibodies against SFTS Group Bandaviruses Suggest New Targets of Specific or Broad-Spectrum Antivirals.
    Fu L; Xu L; Qian J; Wu X; Wang Z; Wang H; Liu D; Deng F; Shen S
    Am J Trop Med Hyg; 2023 Dec; 109(6):1319-1328. PubMed ID: 37931293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV.
    Yang P; Wu X; Shang H; Sun Z; Wang Z; Song Z; Yuan H; Deng F; Shen S; Guo Y; Zhang N
    PLoS Pathog; 2024 Sep; 20(9):e1012550. PubMed ID: 39321193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection.
    Ren X; Sun J; Kuang W; Yu F; Wang B; Wang Y; Deng W; Xu Z; Yang S; Wang H; Hu Y; Deng Z; Ning YJ; Zhao H
    Nat Commun; 2024 Aug; 15(1):7009. PubMed ID: 39147753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets.
    Kwak JE; Kim YI; Park SJ; Yu MA; Kwon HI; Eo S; Kim TS; Seok J; Choi WS; Jeong JH; Lee H; Cho Y; Kwon JA; Jeong M; Maslow JN; Kim YE; Jeon H; Kim KK; Shin EC; Song MS; Jung JU; Choi YK; Park SH
    Nat Commun; 2019 Aug; 10(1):3836. PubMed ID: 31444366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus.
    Dong F; Li D; Wen D; Li S; Zhao C; Qi Y; Jangra RK; Wu C; Xia D; Zhang X; Deng F; Chandran K; Zou Z; Yuan F; Zheng A
    NPJ Vaccines; 2019; 4():5. PubMed ID: 30701094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge.
    Kim D; Lai CJ; Cha I; Kang S; Yang WS; Choi Y; Jung JU
    J Med Virol; 2023 Nov; 95(11):e29203. PubMed ID: 37909776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs.
    Park SC; Jeong DE; Han SW; Chae JS; Lee JY; Kim HS; Kim B; Kang JG
    J Microbiol; 2024 Apr; 62(4):327-335. PubMed ID: 38635002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent immunogenicity and neutralization of recombinant adeno-associated virus expressing the glycoprotein of severe fever with thrombocytopenia virus.
    Shimoyama T; Oba M; Takemae H; Omatsu T; Tani H; Mizutani T
    J Vet Med Sci; 2024 Feb; 86(2):228-238. PubMed ID: 38143087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step.
    Hu Q; Zhang Y; Jiang J; Zheng A
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Conserved Amino Acids within the NSs of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Are Essential for Anti-interferon Activity.
    Moriyama M; Igarashi M; Koshiba T; Irie T; Takada A; Ichinohe T
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Proteomic Analysis Reveals Unfolded-Protein Response Involved in Severe Fever with Thrombocytopenia Syndrome Virus Infection.
    Zhang LK; Wang B; Xin Q; Shang W; Shen S; Xiao G; Deng F; Wang H; Hu Z; Wang M
    J Virol; 2019 May; 93(10):. PubMed ID: 30842332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic evidence of human exposure to the severe fever with thrombocytopenia syndrome virus and associated viruses in Kenya.
    Zohaib A; Zhang J; Agwanda B; Chen J; Luo Y; Hu B; Masika M; Kasiiti Lichoti J; Njeri Waruhiu C; Obanda V; Deng F; Shi Z; Ommeh S; Shen S
    Infect Dis (Lond); 2024 Sep; 56(9):776-782. PubMed ID: 38913503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
    Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C
    Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.